Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

NeoTX Therapeutics Ltd.

Clinical trials sponsored by NeoTX Therapeutics Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental immunotherapy cocktail takes on tough tumors Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Experimental immunotherapy cocktail takes on tough tumors

Disease control Ongoing

This early-phase trial is testing a combination of two immunotherapy drugs, naptumomab estafenatox and durvalumab, in 120 people with advanced or metastatic solid tumors like pancreatic, ovarian, and lung cancer. The main goal is to find a safe dose and see how the body reacts. R…

Phase 1 • Sponsor: NeoTX Therapeutics Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC